Recent News
Dr. Jack Cush reviews the news, journal articles and Gout features from this past week on RheumNow.com.Read Article
Links:
Dr. John Cush @RheumNow ( View Tweet)
Psoriatic Arthritis: EULAR 2026 Recap
Years of IL-17 vs. IL-23 debate in PsA finally got tested head-to-head: bimekizumab outperformed risankizumab on joint outcomes in the BE BOLD trial, while a GLP-1 combination study suggests weight and metabolic status are active drivers of PsA — not just comorbidities. This recap also digs into early signals that biologic choice may influence whether psoriasis progresses to PsA, and why some well-controlled patients are still in pain.
Read Article
Links:


Poster Hall
